|
Regression analysis to determine if there was any significant change in drug availability after the abolition of cost sharing: |
||
| Dependent Variable [Log of Drug Availability] |
||
|
|
||
| Explanatory Variables |
OLS Coefficient |
Random Effects |
|
|
||
| Referral |
-0.071 |
-0.0675 |
| [-1.01] |
[-0.51] |
|
| Public |
1.092*** |
1.085*** |
| [14.55] |
[7.81] |
|
| Choroquine |
-0.0257 |
-0.031 |
| [-0.37] |
[-.045] |
|
| Dummy March 2001 |
-0.074 |
-0.074 |
| [-1.05] |
[-1.07] |
|
| Constant |
1.216 |
9.23 |
| Number of Observations |
2267 |
2267 |
| Number of groups |
- |
32 |
| Adjusted R-Squared |
0.289 |
- |
| F(4,2262) |
56.88 |
- |
| Prob >F |
0 |
- |
| Wald Chi2(4) |
- |
66.8 |
| Prob>chi |
- |
0 |
|
|
||
| Notes: t values in parenthesis |
||
Nabyonga-Orem et al. BMC Health Services Research 2008 8:102 doi:10.1186/1472-6963-8-102 |
||